Yarrow Bioscience (YARW) Total Assets by Year
Yarrow Bioscience, Inc. closed fiscal year 2025 with $30.2M in total assets, $2.4M in total liabilities and $27.8M in shareholder equity. Total assets fell 54.9% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Yarrow Bioscience, Inc. has filed alongside them.
Ticker history: VYNE became YARW (Yarrow Bioscience, Inc.) on . Earlier news and filings retain their original names and dates. View VYNE history.
Annual figures, oldest first. Point at a bar to read its period.
YARW Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-Q | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing | FY17Filing | FY16Filing | FY15Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.2M-54.9% | $66.9M-31.5% | $97.7M+139.7% | $40.8M-39.2% | $67.0M-28.5% | $93.7M+15.5% | $81.2M-42.0% | $139.9M+109.3% | $66.9M+59.0% | $42.1M | N/A |
| Total Liabilities | $2.4M-83.8% | $14.8M+65.6% | $8.9M-4.2% | $9.3M-49.2% | $18.4M-67.3% | $56.2M-11.5% | $63.6M+33.2% | $47.7M+227.6% | $14.6M-79.6% | $71.5M | N/A |
| Total Equity | $27.8M-46.7% | $52.1M-41.3% | $88.7M+184.4% | $31.2M-35.8% | $48.6M+29.7% | $37.5M+113.3% | $17.6M-80.9% | $92.2M+34.4% | $68.6Mn/m | -$29.4Mn/m | -$16.0M |
YARW Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26Filing | Q4'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing | Q3'23Filing | Q2'23Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $23.6M-47.2% | $25.9M-54.1% | $30.2M-54.9% | $44.7M-48.4% | $56.4M-38.5% | $66.9M-31.5% | $76.2M+295.5% | $86.6M+247.2% | $91.7M+160.0% | $97.7M+139.7% | $19.3M-58.9% | $25.0M-54.8% |
| Total Liabilities | $1.5M-73.6% | $1.2M-89.9% | $2.4M-83.8% | $5.8M-50.5% | $12.3M+48.0% | $14.8M+65.6% | $12.7M+63.1% | $11.8M+53.2% | $8.3M-6.0% | $8.9M-4.2% | $7.8M+13.5% | $7.7M+12.5% |
| Total Equity | $22.1M-43.3% | $24.6M-44.2% | $27.8M-46.7% | $38.9M-48.1% | $44.1M-47.1% | $52.1M-41.3% | $63.5M+452.3% | $74.9M+333.5% | $83.4M+215.4% | $88.7M+184.4% | $11.5M-71.3% | $17.3M-64.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Yarrow Bioscience, Inc. financials
Frequently Asked Questions
Yarrow Bioscience, Inc. closed fiscal year 2025 with $30.2M in total assets, $2.4M in total liabilities and $27.8M in shareholder equity.
Yarrow Bioscience, Inc. (YARW) total assets fell by 54.9% year over year, from $66.9M to $30.2M in fiscal year 2025.
Yarrow Bioscience, Inc. (YARW) reported $23.6M in total assets in Q2 2026. This represents a decrease of 47.2% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Yarrow Bioscience, Inc. (YARW) reported on that line in every period on record.